Patents by Inventor Marianne Donnelly

Marianne Donnelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11365199
    Abstract: The present invention relates to pyrazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle stimulating hormone receptor (FSHR).
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: June 21, 2022
    Assignee: Merck Patent GmbH
    Inventors: Henry Yu, Marianne Donnelly, Ngan Nguyen, Xuliang Jiang
  • Publication number: 20180354965
    Abstract: The present invention relates to pyrazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle stimulating hormone receptor (FSHR).
    Type: Application
    Filed: August 22, 2018
    Publication date: December 13, 2018
    Inventors: Henry YU, Marianne DONNELLY, Ngan NGUYEN, Xuliang JIANG
  • Patent number: 10138233
    Abstract: The present invention relates to imidazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle stimulating hormone receptor (FSHR).
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: November 27, 2018
    Assignee: Merck Patent GmbH
    Inventors: Henry Yu, Thomas E. Richardson, Marianne Donnelly, Ngan Nguyen, Xuliang Jiang
  • Patent number: 10081637
    Abstract: The present invention relates to pyrazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle stimulating hormone receptor (FSHR).
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: September 25, 2018
    Assignee: Merck Patent GmbH
    Inventors: Henry Yu, Marianne Donnelly, Ngan Nguyen, Xuliang Jiang
  • Patent number: 9469657
    Abstract: Novel compounds of formula (I) wherein R1 to R4 and X have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: October 18, 2016
    Assignee: Merck Patent GmbH
    Inventors: Marianne Donnelly, Hui Qiu, Henry Yu, Lesley Liu-Bujalski, Andreas Goutopoulos
  • Publication number: 20160152609
    Abstract: The present invention relates to imidazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle stimulating hormone receptor (FSHR).
    Type: Application
    Filed: June 24, 2014
    Publication date: June 2, 2016
    Inventors: Henry YU, Thomas E. RICHARDSON, Marianne DONNELLY, Ngan NGUYEN, Xuliang JIANG
  • Publication number: 20160152626
    Abstract: The present invention relates to pyrazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle stimulating hormone receptor (FSHR).
    Type: Application
    Filed: June 24, 2014
    Publication date: June 2, 2016
    Inventors: Henry YU, Marianne DONNELLY, Nagan NGUYEN, Xuliang JIANG
  • Publication number: 20150111933
    Abstract: The present invention relates to deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor and their use for treating fertility disorders.
    Type: Application
    Filed: January 24, 2013
    Publication date: April 23, 2015
    Applicant: Merck Patent GmbH
    Inventors: Henry Yu, Marianne Donnelly
  • Publication number: 20150018318
    Abstract: Novel compounds of formula (I) wherein R1 to R4 and X have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.
    Type: Application
    Filed: September 30, 2014
    Publication date: January 15, 2015
    Inventors: Marianne Donnelly, Hui Qiu, Henry Yu, Lesley Liu-Bujalski, Andreas Goutopoulos
  • Publication number: 20140243370
    Abstract: Novel compounds of formula (I) wherein R1 to R4 and X have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.
    Type: Application
    Filed: August 22, 2012
    Publication date: August 28, 2014
    Applicant: MERCK PATENT GmbH
    Inventors: Marianne Donnelly, Hui Qiu, Henry Yu, Lesley Liu-Bujalski, Andreas Goutopoulos